Crossref journal-article
Elsevier BV
Biochemical Pharmacology (78)
Bibliography

Monaghan, R. L., & Barrett, J. F. (2006). Antibacterial drug discovery—Then, now and the genomics future. Biochemical Pharmacology, 71(7), 901–909.

Authors 2
  1. Richard L. Monaghan (first)
  2. John F. Barrett (additional)
References 90 Referenced 77
  1. Tuberculosis. Fact Sheet March 2002 National Institute of Allergy and Infectious Diseases. Available at: http://www.niaid.nih.gov/factsheets/tb.htm. Accessed October 17, 2005.
  2. {'key': '10.1016/j.bcp.2005.11.023_bib2', 'series-title': 'Anti-tuberculosis drug resistance in the world', 'author': 'Aziz', 'year': '2004'} / Anti-tuberculosis drug resistance in the world by Aziz (2004)
  3. 10.1016/S0140-6736(60)92303-5 / Lancet / Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936–1955) by Smith (1960)
  4. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments and emergency departments. Report Series 13-#143. Atlanta: National Center for Health Statistics—Center for Disease Control and Prevention; 1999.
  5. NCT 00068120, ORWH:SCOR—Sex/gender factors affecting women's health, Sponsor—National Institute of Diabetes and Digestive and Kidney Diseases [Updated October 11, 2005 Accessed October 16, 2005]. Available at: http://www.ClinicalTrials.gov.
  6. {'key': '10.1016/j.bcp.2005.11.023_bib6', 'series-title': 'Fatal partners: war and disease', 'author': 'Major', 'year': '1941'} / Fatal partners: war and disease by Major (1941)
  7. CDC Emergency Preparedness and Response: Bioterrorism Agents/ Diseases. Available at: http://www.bt.cdc.gov/agent/agentlist.asp. Accessed July 27, 2005.
  8. 10.2174/1381612023394845 / Curr Pharm Des / Genomics in anti-infective drug discovery—getting to endgame by Haney (2002)
  9. 10.1002/art.1780080306 / Arthritis Rheum / Isolation and characterization of Mycoplasma (PPLO) from patients with rheumatoid arthritis, systemic lupus erythematosus and Reiter's syndrome by Bartholomew (1965)
  10. 10.1128/IAI.73.3.1723-1734.2005 / Infect Immun / Age alterations in extent and severity of experimental intranasal infection with Chlamydia pneumoniae in BALB/c mice by Little (2005)
  11. 10.1038/435752a / Nature / Cancer: inflammation by remote control by Mantovani (2005)
  12. 10.1111/j.1365-2036.1990.tb00498.x / Aliment Pharmacol Ther / Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs by Shallcross (1990)
  13. 10.1046/j.1365-2958.1998.01075.x / Mol Microbiol / Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments by Coulter (1998)
  14. 10.1128/JB.186.24.8407-8423.2004 / J Bacteriol / Effect of mild acid on gene expression in Staphylococcus aureus by Weinrick (2004)
  15. 10.1128/JB.186.14.4665-4684.2004 / J Bacteriol / Global gene expression in Staphylococcus aureus biofilms by Beenken (2004)
  16. 10.1128/IAI.72.11.6373-6381.2004 / Infect Immun / Transcriptome of uropathogenic Escherichia coli during urinary tract infection by Snyder (2004)
  17. 10.1046/j.1365-2958.2002.02779.x / Mol Microbiol / Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling by Betts (2002)
  18. {'key': '10.1016/j.bcp.2005.11.023_bib18', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'Preliminary investigations of proteome, metabolome & transcriptone following amoxicillin treatments of S. pneumoniae', 'author': 'Isbister', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / Preliminary investigations of proteome, metabolome & transcriptone following amoxicillin treatments of S. pneumoniae by Isbister (2004)
  19. 10.1016/S0065-2164(08)70013-3 / Adv Appl Microbiol / The actinomycetes and their antibiotics by Waksman (1963)
  20. {'issue': 'Suppl.', 'key': '10.1016/j.bcp.2005.11.023_bib20', 'first-page': '10', 'article-title': 'Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy', 'volume': '45', 'author': 'Bushby', 'year': '1969', 'journal-title': 'Postgrad Med J'} / Postgrad Med J / Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy by Bushby (1969)
  21. 10.1177/1087057103008003011 / J Biomol Screen / High-throughput screen for inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase by surrogate ligand competition by Gottlin (2003)
  22. 10.1016/j.bbapap.2003.11.006 / Biochim Biophys Acta / Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-alanine ligase by Ehmann (2004)
  23. 10.1016/S1056-8719(00)00107-6 / J Pharmacol Toxicol Methods / Drug-like properties and the causes of poor solubility and poor permeability by Lipinski (2000)
  24. {'key': '10.1016/j.bcp.2005.11.023_bib24', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'High throughput screen for inhibitors of Staphylococcus aureus DNA replication', 'author': 'Dean', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / High throughput screen for inhibitors of Staphylococcus aureus DNA replication by Dean (2004)
  25. {'key': '10.1016/j.bcp.2005.11.023_bib25', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'Inhibitors of MurF, an essential cell wall synthesis enzyme', 'author': 'Baum', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / Inhibitors of MurF, an essential cell wall synthesis enzyme by Baum (2004)
  26. 10.1016/S1359-6446(99)01443-9 / Drug Discov Today / The role of natural products in a modern drug discovery program by Strohl (2000)
  27. 10.1016/S1359-6446(02)02556-4 / Drug Discov Today / Chris Lipinski discusses life and chemistry after the rule of five by Owens (2003)
  28. 10.1016/j.copbio.2004.09.002 / Curr Opin Biotechnol / Natural products as a hunting ground for combinatorial chemistry by Ganesan (2004)
  29. Sorensen D, McAlpine J, Piraee M, Farnet C, Zazopoulos E. Genome scanning technology reveals an antibacterial compound (ECO-0501) of a new structural class from the vancomycin-producer Amycolatopsis orientalis. In: 44th ICAAC, Washington, DC, Abstract F-720. American Society of Microbiology: Washington, DC, 2004.
  30. {'issue': '1955–1956', 'key': '10.1016/j.bcp.2005.11.023_bib30', 'first-page': '437', 'article-title': 'The isolation of two synergistic antibiotics from a single fermentation source', 'volume': '3', 'author': 'Celmer', 'year': '1956', 'journal-title': 'Antibiot Annu'} / Antibiot Annu / The isolation of two synergistic antibiotics from a single fermentation source by Celmer (1956)
  31. 10.2174/1568005014606152 / Curr Drug Targets—Infect Disord / Overcoming bacterial resistance by dual target inhibition: the case of streptogramins by Canu (2001)
  32. {'key': '10.1016/j.bcp.2005.11.023_bib32', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'High-throughput screen specific for inhibitors of E. coli PBP1b transpeptidase', 'author': 'Jha', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / High-throughput screen specific for inhibitors of E. coli PBP1b transpeptidase by Jha (2004)
  33. 10.1007/BF01964283 / Eur J Clin Microbiol Infect Dis / Screening of natural products for antimicrobial agents by Silver (1990)
  34. 10.1128/MMBR.64.3.573-606.2000 / Microbiol Mol Biol Rev / Search and discovery strategies for biotechnology: the paradigm shift by Bull (2000)
  35. 10.1016/S1074-5521(98)90108-9 / Chem Biol / Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products by Handelsman (1998)
  36. 10.1038/417141a / Nature / Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) by Bentley (2002)
  37. 10.1007/s00253-002-1143-0 / Appl Microbiol Biotechnol / Impact of the first Streptomyces genome sequence on the discovery and production of bioactive substances by Donadio (2002)
  38. 10.1021/bi982594c / Biochemistry / Structural basis for the design of antibiotics targeting peptide deformylase by Hao (1999)
  39. 10.1021/bi992245y / Biochemistry / Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor by Chen (2000)
  40. 10.1002/pmic.200390043 / Proteomics / The role of peptide deformylase in protein biosynthesis: a proteomic study by Bandow (2003)
  41. 10.1128/AAC.47.8.2545-2550.2003 / Antimicrob Agents Chemother / Subinhibitory concentrations of the deformylase inhiitor actinonin increase bacterial release of neutrophil activating peptides: a new approach to antimicrobial chemotherapy by Fu (2003)
  42. 10.1126/science.1106753 / Science / A Diarylquonoline drug active on the ATP synthase of Mycobacterium tuberculosis by Andries (2005)
  43. NCT 00102947, Daptomycin in the treatment of patients with renal insufficiency and complicated skin and skin structure infections. Sponsor—Cubist Pharmaceuticals [Updated August 1, 2005; Accessed October 16, 2005]. Available at: http://www.ClinicalTrials.gov; 2005.
  44. NCT 00091819, Comparison of Telavancin and Vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant Staphylococcus aureus (Atlas 1). Sponsor—Theravance [Updated August 1, 2005; Accessed October 16, 2005]. Available at: http://www.ClinicalTrials.gov; 2005.
  45. 10.1345/aph.1E397 / Ann Pharmacol / Ramoplanin: a lipoglycodepsipeptide antibiotic by Farver (2005)
  46. 10.1128/AAC.11.5.852 / Antimicrob Agents Chemother / Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus by Reading (1977)
  47. 10.1046/j.1365-2672.92.5s1.16.x / J Appl Microbiol / Novel targets for the future development of antibacterial agents by McDevitt (2002)
  48. 10.1517/phgs.5.1.101.25679 / Pharmacogenomics / Identification of antimicrobial targets using a comprehensive genomic approach by Yin (2004)
  49. 10.1128/AEM.65.11.5023-5027.1999 / Appl Environ Microbiol / Stress responses as a tool to detect and characterize the mode of action of antibacterial agents by Bianchi (1999)
  50. 10.1073/pnas.252607699 / Proc Natl Acad Sci USA / Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics by Goh (2002)
  51. 10.1016/j.chembiol.2004.07.010 / Chem Biol / Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome by Tsui (2004)
  52. {'issue': '2', 'key': '10.1016/j.bcp.2005.11.023_bib52', 'first-page': '109', 'article-title': 'Antibacterial antisense', 'volume': '7', 'author': 'Geller', 'year': '2005', 'journal-title': 'Curr Opin Mol Ther'} / Curr Opin Mol Ther / Antibacterial antisense by Geller (2005)
  53. 10.1016/S0378-1097(03)00931-5 / FEMS Microbiol Lett / Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus by Ji (2004)
  54. 10.1128/JB.185.1.359-370.2003 / J Bacteriol / Transcriptional regulation and signature patterns revealed by microarray analysis of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors by Ng (2003)
  55. 10.1099/mic.0.26426-0 / Microbiology / Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon by Utaida (2003)
  56. 10.1016/j.femsle.2005.01.018 / FEMS Microbiol Lett / Global gene expression profile of Yersinia pestis induced by streptomycin by Oiu (2005)
  57. 10.1128/AEM.70.8.4941-4949.2004 / Appl Environ Microbiol / Differential gene expression to investigate the effect of (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone on Bacillus subtilis by Ren (2004)
  58. 10.1128/AAC.49.5.1915-1926.2005 / Antimicrob Agents Chemother / Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis by Lin (2005)
  59. 10.1126/science.1063566 / Science / Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA by Ji (2001)
  60. 10.1128/AAC.47.3.948-955.2003 / Antimicrob Agents Chemother / Proteomic approach to understanding antibiotic action by Bandow (2003)
  61. 10.1016/j.chembiol.2004.08.014 / Chem Biol / Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility by Li (2004)
  62. 10.1128/JB.183.24.7341-7353.2001 / J Bacteriol / Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci by Dunman (2001)
  63. 10.1073/pnas.0504922102 / Proc Natl Acad Sci USA / Mutually dependent secretion of proteins required for mycobacterial virulence by Fortune (2005)
  64. 10.1128/AAC.48.8.3057-3063.2004 / Antimicrob Agents Chemother / Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus by Pechous (2004)
  65. {'key': '10.1016/j.bcp.2005.11.023_bib65', 'series-title': 'Principles for the management of drug resistant tuberculosis', 'author': 'Crofton', 'year': '1996'} / Principles for the management of drug resistant tuberculosis by Crofton (1996)
  66. 10.2217/14750708.2.4.511 / Therapy / Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs? by Blondeau (2005)
  67. 10.1016/S0025-7125(05)70294-7 / Med Clin North Am / Antibiotic synergy and antagonism by Acer (2000)
  68. {'key': '10.1016/j.bcp.2005.11.023_bib68', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'Construction of a novel Pseudomonas aeruginosa strain panel deficient in fifty-two potential drug efflux systems', 'author': 'Duncan', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / Construction of a novel Pseudomonas aeruginosa strain panel deficient in fifty-two potential drug efflux systems by Duncan (2004)
  69. 10.1128/AAC.49.2.565-570.2005 / Antimicrob Agents Chemother / Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multi-drug resistance in Pseudomonas aeruginosa by Kriengkauykiat (2005)
  70. {'key': '10.1016/j.bcp.2005.11.023_bib70', 'series-title': '44th Interscience conference on antimicrobial agents and chemotherapy', 'article-title': 'In vivo efficacy of the bacterial type III protein secretion systems (TTPS) inhibitors JNJ-10275798 and JNJ-10278385', 'author': 'Fernandez', 'year': '2004'} / 44th Interscience conference on antimicrobial agents and chemotherapy / In vivo efficacy of the bacterial type III protein secretion systems (TTPS) inhibitors JNJ-10275798 and JNJ-10278385 by Fernandez (2004)
  71. 10.1093/jac/dkg044 / J Antimicrob Chemother / A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus by Gibbons (2003)
  72. 10.1615/CritRevImmunol.v20.i5.40 / Crit Rev Immunol / Cationic antimicrobial peptides and their multifunctional role in the immune system by Scott (2000)
  73. 10.1128/AAC.49.5.1727-1732.2005 / Antimicrob Agents Chemother / Immunomodulatory activities of small host defense peptides by Bowdish (2005)
  74. 10.4049/jimmunol.165.6.3358 / J Immunol / An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression by Scott (2000)
  75. 10.1016/0006-2952(88)90187-6 / Biochem Pharmacol / Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils by Charp (1988)
  76. 10.1128/AAC.48.10.3749-3757.2004 / Antimicrob Agents Chemother / Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus by Koehl (2004)
  77. 10.1126/science.1106442 / Science / Immunity, inflammation, and allergy in the gut by MacDonald (2005)
  78. Obst U, Volkmann H, Schwartz T, Kirchen S. Oligonucleotide, method and system for detecting antibiotic resistance-mediating genes in microorganisms by means of real-time PCR. Patent US20050059064 A1; 2005.
  79. 10.1128/AAC.48.11.4293-4300.2004 / Antimicrob Agents Chemother / Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR by Marin (2004)
  80. 10.1126/science.1110699 / Science / A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA by Hegde (2005)
  81. {'key': '10.1016/j.bcp.2005.11.023_bib81', 'first-page': '364', 'article-title': 'Toxicogenomics: history and current applications', 'volume': '70', 'author': 'Weber', 'year': '2004', 'journal-title': 'ASM News'} / ASM News / Toxicogenomics: history and current applications by Weber (2004)
  82. 10.1128/AAC.49.5.1733-1738.2005 / Antimicrob Agents Chemother / Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? by Kinzig-Schippers (2005)
  83. 10.1110/ps.041163505 / Protein Sci / Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis by Sandy (2005)
  84. 10.1126/science.308.5730.1858 / Science / Going from genome to pill by Service (2005)
  85. 10.1002/art.1780070410 / Arthritis Rheum / The Mycoplasmataceae (PPLO) as causes of joint infections by Sharp (1964)
  86. 10.2165/00003495-200464010-00005 / Drugs / The glycylcyclines: a comparative review with the tetracyclines by Zhanel (2004)
  87. {'issue': '3', 'key': '10.1016/j.bcp.2005.11.023_bib87', 'first-page': '433', 'article-title': 'Polymerase chain reaction confirmed Mycoplasma pneumoniae arthritis: a case report', 'volume': '46', 'author': 'Chaudhry', 'year': '2003', 'journal-title': 'Indian J Pathol Microbiol'} / Indian J Pathol Microbiol / Polymerase chain reaction confirmed Mycoplasma pneumoniae arthritis: a case report by Chaudhry (2003)
  88. 10.1056/NEJMoa043528 / N Engl J Med / Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome by Cannon (2005)
  89. 10.1056/NEJMoa043526 / N Engl J Med / Azithromycin for the secondary prevention of coronary events by Grayston (2005)
  90. 10.1056/NEJMe058019 / N Engl J Med / Infection, antibiotics and atherothrombosis—end of the road or new beginnings? by Anderson (2005)
Dates
Type When
Created 19 years, 6 months ago (Feb. 22, 2006, 7:25 a.m.)
Deposited 5 years, 4 months ago (April 12, 2020, 5:19 p.m.)
Indexed 1 week, 4 days ago (Aug. 23, 2025, 1:02 a.m.)
Issued 19 years, 6 months ago (March 1, 2006)
Published 19 years, 6 months ago (March 1, 2006)
Published Print 19 years, 6 months ago (March 1, 2006)
Funders 0

None

@article{Monaghan_2006, title={Antibacterial drug discovery—Then, now and the genomics future}, volume={71}, ISSN={0006-2952}, url={http://dx.doi.org/10.1016/j.bcp.2005.11.023}, DOI={10.1016/j.bcp.2005.11.023}, number={7}, journal={Biochemical Pharmacology}, publisher={Elsevier BV}, author={Monaghan, Richard L. and Barrett, John F.}, year={2006}, month=mar, pages={901–909} }